{
  "_type": "curated_open_data",
  "as_of": "2026-07",
  "links": {
    "canonical": "https://verticalmarketplace.ai",
    "docs_for_llms": "https://verticalmarketplace.ai/llms.txt",
    "sell_your_own": "https://verticalmarketplace.ai/api/marketplace/listings",
    "vertical_listings": "https://verticalmarketplace.ai/api/marketplace/listings?vertical=pharma"
  },
  "records": [
    {
      "term": "National Drug Code (NDC)",
      "category": "identifiers",
      "reference": "Three segments for labeler, product, and package",
      "definition": "A unique product identifier for drugs marketed in the U.S."
    },
    {
      "term": "RxNorm",
      "category": "identifiers",
      "reference": "Maintained by the National Library of Medicine",
      "definition": "A normalized naming system for clinical drugs that links drug vocabularies"
    },
    {
      "term": "Anatomical Therapeutic Chemical (ATC) classification",
      "category": "classification",
      "reference": "Maintained by the WHO",
      "definition": "A system grouping drugs by organ system and therapeutic and chemical properties"
    },
    {
      "term": "Active pharmaceutical ingredient (API)",
      "category": "quality",
      "reference": "Distinct from inactive ingredients",
      "definition": "The substance in a drug that produces the intended therapeutic effect"
    },
    {
      "term": "Bioequivalence",
      "category": "regulation",
      "reference": "Basis for generic approval",
      "definition": "Demonstration that a generic delivers the active ingredient at a comparable rate and extent as the reference drug"
    },
    {
      "term": "Adverse event",
      "category": "safety",
      "reference": "Reported to FAERS",
      "definition": "Any undesirable experience associated with the use of a drug"
    },
    {
      "term": "Pharmacovigilance",
      "category": "safety",
      "reference": "Ongoing postmarket monitoring",
      "definition": "The science of detecting, assessing, and preventing drug-related harm"
    },
    {
      "term": "Orange Book therapeutic-equivalence code",
      "category": "classification",
      "reference": "Codes beginning with 'A' indicate equivalence",
      "definition": "A code showing whether a product is therapeutically equivalent to a reference drug"
    },
    {
      "term": "Risk Evaluation and Mitigation Strategy (REMS)",
      "category": "regulation",
      "reference": "Applies to selected drugs",
      "definition": "A safety program the FDA can require to ensure benefits outweigh risks"
    },
    {
      "term": "Drug Master File (DMF)",
      "category": "regulation",
      "reference": "Referenced by applications",
      "definition": "Confidential submission with information about facilities, processes, or materials"
    },
    {
      "term": "Current Good Manufacturing Practice (cGMP)",
      "category": "quality",
      "reference": "Enforced through inspections",
      "definition": "FDA requirements ensuring drugs are produced consistently and to quality standards"
    },
    {
      "term": "NDA, ANDA, and BLA",
      "category": "regulation",
      "reference": "Distinct statutory pathways",
      "definition": "The main application types for new drugs, generics, and biologics"
    },
    {
      "term": "Excipient",
      "category": "quality",
      "reference": "Serves as a binder, filler, or carrier",
      "definition": "An inactive ingredient included in a drug formulation"
    },
    {
      "term": "Controlled substance schedule",
      "category": "regulation",
      "reference": "Schedule I has no accepted medical use",
      "definition": "DEA classification of drugs by abuse potential from Schedule I to Schedule V"
    }
  ],
  "sources": [
    {
      "url": "https://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory",
      "name": "FDA — National Drug Code Directory"
    },
    {
      "url": "https://www.dea.gov/drug-information/drug-scheduling",
      "name": "DEA — Drug Scheduling"
    }
  ],
  "category": "glossary",
  "vertical": "pharma",
  "data_note": "All records are public-domain facts compiled from the cited sources as of the asOf date. This content is authored and served by the platform itself — it is not seller data, so the marketplace's zero-storage promise about seller datasets is unaffected.",
  "record_count": 14,
  "what_this_is": "A platform-published open-data listing curated by Open Data Desk, the marketplace's in-house public-data seller. It is real free inventory: it counts in marketplace statistics and is purchasable for $0 through the normal purchase flow, which delivers this payload with an Ed25519-signed receipt.",
  "record_schema": {
    "term": "The drug code, identifier, or regulatory term",
    "category": "Grouping such as identifiers, quality, or regulation",
    "reference": "Standard, agency, or clarifying note",
    "definition": "Plain-language meaning"
  },
  "buyer_use_cases": [
    "Standardize drug coding and regulatory terminology across teams",
    "Ground a pharma assistant with precise, citable definitions",
    "Support onboarding and documentation with a ready glossary"
  ]
}